Tushar Shah - Articles and news items


Teva announces FDA acceptance of NDA filing for investigational short-acting beta-agonist inhaler (Albuterol MDPI)

Industry news / 14 July 2014 / Teva

First breath-actuated dry-powder SABA inhaler to be accepted by FDA for review…


Teva announces FDA approval of QNASLTM

Industry news, News / 26 March 2012 / Teva Pharmaceutical Industries Ltd

New treatment with “dry” mode of delivery seeks to address unmet needs of seasonal and perennial allergy sufferers…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...